ICU leaders need to be current with recent technological advances related to cardiac implantable electrical devices (CIEDs). This update will review the following 4 topics: (1) an update on contemporary technology for CIED companies headquartered in the United States, (2) unique features of one CIED company headquartered in Europe, (3) ICU considerations for patients with CIEDs for whom do not resuscitate orders are in place, and (4) evaluation of patients admitted to the ICU with incomplete medical information about a visible medical device that may be a CIED. This discussion will provide valuable information for the care of ICU patients with CIED.
RoznerM. Pacemakers and implantable cardioverter defibrillators. Crit Care Med. 2004;32:1809-1812.
2.
Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices. Anesthesiology. 2011;114:247-261.
3.
KapaSMuellerPSHayesDLAsirvathamSJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc. 2010;85:981-990.
